Antimicrobial resistance in Neisseria gonorrhoeae.
Despite a declining incidence of gonorrhea in much of the industrialized world, antimicrobial resistance continues to present a challenge to the treatment of gonococcal infections. Although no clinically significant resistance to the broad-spectrum cephalosporins has been identified, fluoroquinolone-resistant gonococcal strains are now prevalent in Australia and much of the Far East. Ongoing surveillance for antimicrobial resistance is crucial to obtain the information needed to choose effective empiric therapies for gonorrhea.
Fox
K K
KK
Epidemiology and Surveillance Branch, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. kim_fox@mail.enr.state.nc.us
Knapp
J S
JS
D004352:Drug Resistance, Microbial; D014943:Global Health; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D011159:Population Surveillance; D015995:Prevalence; D016036:Seroepidemiologic Studies